Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Zürcher T[au]:

The notion of free will and its ethical relevance for decision-making capacity. Zürcher T et al. BMC Med Ethics. (2019)

Highly efficient ketone body treatment in multiple acyl-CoA dehydrogenase deficiency-related leukodystrophy. Gautschi M et al. Pediatr Res. (2015)

Replication of orthomyxoviruses. Portela A et al. Adv Virus Res. (1999)

Search results

Items: 29

1.

The notion of free will and its ethical relevance for decision-making capacity.

Zürcher T, Elger B, Trachsel M.

BMC Med Ethics. 2019 May 8;20(1):31. doi: 10.1186/s12910-019-0371-0.

2.

Highly efficient ketone body treatment in multiple acyl-CoA dehydrogenase deficiency-related leukodystrophy.

Gautschi M, Weisstanner C, Slotboom J, Nava E, Zürcher T, Nuoffer JM.

Pediatr Res. 2015 Jan;77(1-1):91-8. doi: 10.1038/pr.2014.154. Epub 2014 Oct 7.

PMID:
25289702
3.

Chimeric infectious bursal disease virus-like particles as potent vaccines for eradication of established HPV-16 E7-dependent tumors.

Martin Caballero J, Garzón A, González-Cintado L, Kowalczyk W, Jimenez Torres I, Calderita G, Rodriguez M, Gondar V, Bernal JJ, Ardavín C, Andreu D, Zürcher T, von Kobbe C.

PLoS One. 2012;7(12):e52976. doi: 10.1371/journal.pone.0052976. Epub 2012 Dec 31.

4.

Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro.

Zürcher T, Yates PJ, Daly J, Sahasrabudhe A, Walters M, Dash L, Tisdale M, McKimm-Breschkin JL.

J Antimicrob Chemother. 2006 Oct;58(4):723-32. Epub 2006 Aug 5.

PMID:
16891631
5.

Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations.

Jackson D, Barclay W, Zürcher T.

J Antimicrob Chemother. 2005 Feb;55(2):162-9. Epub 2005 Jan 21.

PMID:
15665027
6.
7.

Defective RNA replication and late gene expression in temperature-sensitive influenza viruses expressing deleted forms of the NS1 protein.

Falcón AM, Marión RM, Zürcher T, Gómez P, Portela A, Nieto A, Ortín J.

J Virol. 2004 Apr;78(8):3880-8.

8.

Urinary iodine concentration during pregnancy in an area of unstable dietary iodine intake in Switzerland.

Brander L, Als C, Buess H, Haldimann F, Harder M, Hänggi W, Herrmann U, Lauber K, Niederer U, Zürcher T, Bürgi U, Gerber H.

J Endocrinol Invest. 2003 May;26(5):389-96.

9.

A reverse genetics approach for recovery of recombinant influenza B viruses entirely from cDNA.

Jackson D, Cadman A, Zurcher T, Barclay WS.

J Virol. 2002 Nov;76(22):11744-7.

10.
11.

Ultrastructural and functional analyses of recombinant influenza virus ribonucleoproteins suggest dimerization of nucleoprotein during virus amplification.

Ortega J, Martín-Benito J, Zürcher T, Valpuesta JM, Carrascosa JL, Ortín J.

J Virol. 2000 Jan;74(1):156-63.

12.

Replication of orthomyxoviruses.

Portela A, Zürcher T, Nieto A, Ortín J.

Adv Virus Res. 1999;54:319-48. Review. No abstract available.

PMID:
10547678
13.

In vivo reconstitution of active Thogoto virus polymerase: assays for the compatibility with other orthomyxovirus core proteins and template RNAs.

Weber F, Jambrina E, González S, Dessens JT, Leahy M, Kochs G, Portela A, Nuttall PA, Haller O, Ortín J, Zürcher T.

Virus Res. 1998 Nov;58(1-2):13-20.

PMID:
9879758
14.

Influenza virus NS1 protein interacts with viral transcription-replication complexes in vivo.

Marión RM, Zürcher T, de la Luna S, Ortín J.

J Gen Virol. 1997 Oct;78 ( Pt 10):2447-51.

PMID:
9349463
16.
17.

A plasmid-based reverse genetics system for influenza A virus.

Pleschka S, Jaskunas R, Engelhardt OG, Zürcher T, Palese P, García-Sastre A.

J Virol. 1996 Jun;70(6):4188-92.

18.

The amino-terminal one-third of the influenza virus PA protein is responsible for the induction of proteolysis.

Sanz-Ezquerro JJ, Zürcher T, de la Luna S, Ortín J, Nieto A.

J Virol. 1996 Mar;70(3):1905-11.

19.

[Reply to "So the itch remains bearable" 10/95. Treatment of eczema--the Bernese version].

Imboden E, Zürcher T.

Krankenpfl Soins Infirm. 1995 Dec;88(12):64-6. German. No abstract available.

PMID:
8691812
20.
21.

Nuclear localization of mouse Mx1 protein is necessary for inhibition of influenza virus.

Zürcher T, Pavlovic J, Staeheli P.

J Virol. 1992 Aug;66(8):5059-66.

22.

Mechanism of human MxA protein action: variants with changed antiviral properties.

Zürcher T, Pavlovic J, Staeheli P.

EMBO J. 1992 Apr;11(4):1657-61.

23.

Mouse Mx2 protein inhibits vesicular stomatitis virus but not influenza virus.

Zürcher T, Pavlovic J, Staeheli P.

Virology. 1992 Apr;187(2):796-800.

PMID:
1312277
24.
25.

Nuclear myxovirus-resistance protein Mx is a minor histocompatibility antigen.

Speiser DE, Zürcher T, Ramseier H, Hengartner H, Staeheli P, Haller O, Zinkernagel RM.

Proc Natl Acad Sci U S A. 1990 Mar;87(5):2021-5.

26.
27.

Effect of supplemental zinc on growth and on hair and blood serum levels of beef cattle.

Beeson WM, Perry TW, Zurcher TD.

J Anim Sci. 1977 Jul;45(1):160-5. No abstract available.

PMID:
885817
28.

Further observations on plasma somatomedin activity in children.

van den Brande JL, van Buul S, Heinrich U, van Roon F, Zurcher T, van Steirtegem AC.

Adv Metab Disord. 1975;8:171-81. No abstract available.

PMID:
1199888
29.

Glucose-6-phosphate dehydrogenase deficiency in females, diagnosed by partial inhibition of glutathione reductase activity in the erythrocytes after incubation with chromate.

Zurcher C, Kuijlman FF, Sass F't, Zurcher T, Loos JA, Prins HK.

Clin Chim Acta. 1969 Jul;25(1):139-46. No abstract available.

PMID:
5797116

Supplemental Content

Loading ...
Support Center